Answers are grounded in this paper and cite their sources.
Ebola causes severe hemorrhagic fever in humans and nonhuman primates, and there are currently no approved therapeutic countermeasures. The virulence of Ebola virus (EBOV) may be partially attributed to the secreted glycoprotein (sGP), which is the main product transcribed from its GP gene. sGP is secreted from infected cells and can be readily detected in the serum of EBOV-infected hosts. This review summarizes the multiple roles that sGP may play during infection and highlights the implications for the future design of vaccines and treatments.
No takes yet. Share an insight, caveat, or question.
Vega et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: